¾ÅÖÝÓ°Ôº

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Cell Penetrating Peptides

7 - 10 October 2013, London, United Kingdom


Introduction
The study of cell penetrating peptides (CPPs) now extends into a third exciting decade and it is certain that these mostly cationic sequences (e.g. TAT; GRKKRRQRRRPQ) have enormous potential in biomedicine. Thus, an extended range of inert CPPs has proven utility for the delivery of highly active cargoes (peptide, proteins, drugs and oligonucleotides) able to influence the expression and function of intracellular targets. Moreover, targeting sequences can more selectively direct CPPs to specific cell and tissue types and so improve both pharmacokinetic and pharmacodynamic profiles. More recent applications of CPPs in vivo, coupled with the development of bioactive CPPs (bioportides), provides further scope to employ CPPs as research tools, diagnostics and therapeutics.

In addition to lectures covering contemporary aspects of CPP design, synthesis and applications, four workshops will enable all delegates to consider their current and anticipated research activities and design CPPs that might be applied to support these. Thus, the conference will specifically provide a holistic framework to include modern methods of synthesis, CPP design (including targeting) and considerations of pharmacodynamics and pharmacokinetics that can be manipulated to achieve a desirable action of CPP-delivered bioactive cargoes either in vitro or in vivo.

Useful links

Venue
The Royal Society

The Royal Society, 6–9 Carlton House Terrace, London, SW1Y 5AG, United Kingdom

Organised by
Biochemical society / FEBS
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*